Getinge launches NICCI for advanced hemodynamic monitoring
Getinge announced NICCI, which delivers advanced hemodynamic monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure.
Blood pressure is one of the most important variables evaluated during almost every surgical intervention, but recent studies show that fluctuations in blood pressure may be missed due to standard intermittent readings. These occurring blood pressure drops, called hypotensions, result in complications which can get severe and even life threatening. They can however be reduced by continuous, noninvasive blood pressure monitoring.
“With NICCI, hemodynamic monitoring has never been easier. While measuring continuously and non-invasively, NICCI provides a complete picture of the patient’s individual hemodynamic status – ensuring the medical staff that they never miss a beat,” says Clemens Brühl, Head of Product Management Advanced Patient Monitoring at Getinge.
NICCI has been awarded with the Red Dot Award 2020 for its design. With dynamic parameters like cardiac index (CI), stroke volume variation (SVV) and pulse pressure variation (PPV) NICCI guides individual treatment decisions for example related to Goal Directed Fluid Therapy (GDFT).
“It has a sensor that comes in three sizes, containing two finger cuffs that perform an automatically alternating continuous measurement from one finger to the other after no more than an hour. This enables continuous use of NICCI for up to 72 hours,” explains Clemens Brühl.
NICCI is based on the Continuous Noninvasive Arterial Pressure Technology (CNAP). It allows the anesthesiologist to assess the patients’ hemodynamic status even before induction of anesthesia and after surgery. Main application area is before, during and after surgery as well as in post-operative care units, but also emergency rooms and cath-labs.
